Literature DB >> 24000216

Non-typeable Haemophilus influenzae infective endocarditis in a renal transplant recipient: compromised host or virulent strain?

Lauren A Bertelle-Ibrahim1, Timothy F Murphy, Charmaine Kirkham, Ganapathi I Parameswaran, Charles S Berenson.   

Abstract

Non-typeable Haemophilus influenzae (NTHI) rarely cause endocarditis. Of the limited reports of H influenzae endocarditis, most have been due to encapsulated organisms or have had limited bacterial characterisation. We encountered a transplant recipient with native valve NTHI endocarditis and were intrigued to find no previous descriptions of this entity. Although it was tempting to ascribe this infection to our patient's immunocompromised status, we investigated his pathogen further and found that it displayed features common to invasive NTHI strains including gene expression for two IgA proteases and serum resistance. Multilocus sequence typing grouped our NTHI strain with MLST 159, a group associated with invasive NTHI infections. Our strain shared identical outer membrane protein P2 sequences and protein patterns with MLST 159 strains. Aside from providing the first characterisation of native valve NTHI infection, our investigation reveals features of epidemiologically unrelated, clonal NTHI strains that have a predilection for invasive infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24000216      PMCID: PMC3794229          DOI: 10.1136/bcr-2013-200377

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Haemophilus influenzae type b endocarditis in a woman with mitral valve prolapse.

Authors:  Kostis Georgilis; Sofokles Kontoyannis; Helen Prifti; Vassiliky Petrocheilou-Paschou
Journal:  Clin Microbiol Infect       Date:  1998-02       Impact factor: 8.067

2.  Type b and non-type b Haemophilus influenzae endocarditis.

Authors:  S R Csukas; F Elbl; G S Marshall
Journal:  Pediatr Infect Dis J       Date:  1992-12       Impact factor: 2.129

3.  Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group.

Authors:  C Darras-Joly; O Lortholary; J L Mainardi; J Etienne; L Guillevin; J Acar
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

Review 4.  Fatal Haemophilus influenzae endocarditis.

Authors:  N M Kernohan; A J Paterson
Journal:  J Infect       Date:  1989-07       Impact factor: 6.072

5.  Characterization of igaB, a second immunoglobulin A1 protease gene in nontypeable Haemophilus influenzae.

Authors:  Matthew M Fernaays; Alan J Lesse; Xueya Cai; Timothy F Murphy
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old.

Authors:  Mark S Dworkin; Lee Park; Stephanie M Borchardt
Journal:  Clin Infect Dis       Date:  2007-02-01       Impact factor: 9.079

Review 7.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

8.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

9.  Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae.

Authors:  D J Sikkema; T F Murphy
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae.

Authors:  Shigeki Nakamura; Mikhail Shchepetov; Ankur B Dalia; Sarah E Clark; Timothy F Murphy; Sanjay Sethi; Janet R Gilsdorf; Arnold L Smith; Jeffery N Weiser
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.